Evidence map›Paper›PMID 40693336›Full record

ArticleJournal of diabetes2025

Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012-2021.

Shanshan Li, Shaoxi Pan, Nan Xiao, Shaoxiang Jiang, Gorden G Liu, Beini Lyu

Erratum issuedAbstract readLetter
In one paragraph

Article in Journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Shanshan LiDepartment of Global Health, School of Public Health, Peking University, Beijing, China.ORCID https://orcid.org/0000-0001-9704-7101
Shaoxi PanChina Center for Health Economic Research, Peking University, Beijing, China.
Nan XiaoInstitute for Global Health and Development, Peking University, Beijing, China.
Shaoxiang JiangInstitute for Global Health and Development, Peking University, Beijing, China.
Gorden G LiuInstitute for Global Health and Development, Peking University, Beijing, China.
Beini LyuInstitute for Global Health and Development, Peking University, Beijing, China.

Funding

National Natural Science Foundation of China 72404006
6 · The paper itself

Abstract

Glucose-lowering medication expenditures per user by different payers among patients with diabetes.

Indexed as

Diabetes MellitusDrug CostsHealth ExpendituresHypoglycemic AgentsPrescription DrugsHumansUnited StatesHypoglycemic AgentsPrescription Drugsglucose‐lowering drugsMedicaremedication expendituresnon‐glucose‐lowering drugsprivate insurance

Identifiers

PMID40693336
PMCPMC12280806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.